Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

ClinicalTrials.gov ID: NCT00896337

Public ClinicalTrials.gov record NCT00896337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 6:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Boston Scientific Trial of the EPIC™ Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

Study identification

NCT ID
NCT00896337
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
125 participants

Conditions and interventions

Interventions

  • Anti-coagulation therapy Drug
  • Anti-platelet therapy Drug
  • Epic™ Nitinol Stent System Device

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2009
Primary completion
Aug 31, 2011
Completion
Nov 30, 2013
Last update posted
May 6, 2015

2009 – 2013

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
St. Joseph's Hospital Tucson Arizona 85710
Brandon Regional Hospital Brandon Florida 33511
Holy Cross Hospital Fort Lauderdale Florida 33308
Mediquest Research at Munroe Regional Medical Center Ocala Florida 34471
Piedmont Hospital Atlanta Georgia 30309
Wellstar Kennestone Hospital Marietta Georgia 46805
Advocate Christ Medical Center Oak Lawn Illinois 60453
Parkview Hospital-Parkview Research Center Fort Wayne Indiana 46805
St. Vincent's Hospital Indianapolis Indiana 46290
Trinity Terrace Park Davenport Iowa 52803
University of Michigan Ann Arbor Michigan 48109
North Memorial Medical Center Robbinsdale Minnesota 55422
Mount Sinai Medical Center New York New York 10029
Mid-Carolina Cardiology - Presbyterian Hospital Charlotte North Carolina 28204
Wake Medical Center Raleigh North Carolina 27610
MeritCare Hospital Fargo North Dakota 58102
Cleveland Clinic Cleveland Ohio 44195
Ohio State University Medical Center Columbus Ohio 43210
Grant Medical Center Columbus Ohio 43215
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104
UPMC - Shadyside Hospital Pittsburgh Pennsylvania 15232
York Hospital York Pennsylvania 17405
Rhode Island Hospital Providence Rhode Island 02903
Erlanger Medical Center Chattanooga Tennessee 37403
St. Thomas Research Institute Nashville Tennessee 37205
VA North Texas Health Care System Dallas Texas 75216
Baptist Hospital of San Antonio San Antonio Texas 78205
Fletcher Allen Health Care Burlington Vermont 05401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00896337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2015 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00896337 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →